Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies. - Gordon SC; Villamil A; Jacobson IM; Lawitz EJ; Younes Z; Silveira MG; Bowlus CL; Drenth JPH; Vierling JM; Morgera U; Vasura A; Dalekos G; et al. (Hepatology communications, 2026)